Rheumatology Advance Access published online on September 7, 2004
Rheumatology, doi:10.1093/rheumatology/keh397
Rheumatology © British Society for Rheumatology 2004; all rights reserved
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Division of Rheumatology, Department of Medical and Surgical Sciences, University of Padua, Padua, Italy
* To whom correspondence should be addressed. E-mail: adoria{at}unipd.it.
Objective. To examine health-related quality of life (HRQOL) in Italian patients with systemic lupus erythematosus (SLE) and compare it with that of healthy people, and to investigate relationships among different dimensions and subscales of a generic health status measure. Methods. The Medical Outcomes Study Short Form-36 (SF-36) was applied in a cohort of 126 consecutive SLE patients and 96 healthy controls. At the time of HRQOL testing, all patients underwent clinical and laboratory evaluation. Results. Both physical (PCS) and mental (MCS) component summary scores of the SF-36 were reduced in patients compared with controls. In SLE great variability in all the subscales was observed. Significant correlations between PCS and MCS and between many different subscales were observed in patients but not in controls. The PCS was higher than MCS more frequently in controls than in SLE patients (81 vs 48.4%, P<0.00001). In SLE, HRQOL tended to worsen with age. Conclusion. Both PCS and MCS contribute to the decrease in HRQOL in SLE patients. In SLE the mutual interaction between these two dimensions seems to be more relevant than in healthy people.
Accepted August 6, 2004
Original Papers
Health-related quality of life in Italian patients with systemic lupus erythematosus. I. Relationship between physical and mental dimension and impact of age
2 Department of Rheumatology, University of Ancona, Ancona, Italy
3 Department of Neuroscience, University of Padua, Padua, Italy
4 Rheumatology Unit, L. Sacco Hospital, Milan, Italy
Abstract 
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. APPENZELLER, A. E. CLARKE, P. PANOPALIS, L. JOSEPH, Y. ST. PIERRE, and T. LI The Relationship Between Renal Activity and Quality of Life in Systemic Lupus Erythematosus J Rheumatol, May 1, 2009; 36(5): 947 - 952. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Dussan, L Magder, R. Brodsky, R. Jones, and M Petri High dose cyclophosphamide performs better than monthly dose cyclophosphamide in quality of life measures Lupus, December 1, 2008; 17(12): 1079 - 1085. [Abstract] [PDF]
|
|
|
|
|
|
A Doria and C Briani Lupus: improving long-term prognosis Lupus, March 1, 2008; 17(3): 166 - 170. [Abstract] [PDF]
|
|
|
|
 |
|
 A M Bertoli, M Fernandez, G S Alarcon, L M Vila, J D Reveille, and for the LUMINA Study Group Systemic lupus erythematosus in a multiethnic US cohort LUMINA (XLI): factors predictive of self-reported work disability Ann Rheum Dis, January 1, 2007; 66(1): 12 - 17. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A Doria, L Iaccarino, S Arienti, M E Rampudda, M G Canova, R Rondinone, and S Todesco Mycophenolate mofetil and systemic lupus erythematosus Lupus, November 1, 2006; 15(11_suppl): 44 - 54. [Abstract] [PDF]
|
|
|
|
|
|
K Mcelhone, J Abbott, and L -S Teh A review of health related quality of life in systemic lupus erythematosus Lupus, October 1, 2006; 15(10): 633 - 643. [Abstract] [PDF]
|
|
|
|
|
|
M Abu-Shakra, A Keren, I Livshitz, V Delbar, A Bolotin, S Sukenik, and Y Kanat-Maymon Sense of coherence and its impact on quality of life of patients with systemic lupus erythematosus Lupus, January 1, 2006; 15(1): 32 - 37. [Abstract] [PDF]
|
|